6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE

6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE Structure
CAS No.
73963-62-9
Chemical Name:
6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE
Synonyms
OPC-13015;Cilostazol USP RC B;3,4-Dehydro Cilostazol;1H-tetrazol-5-yl)butoxy]-;cilostazol impurity B / RC-B;Cilostazol Related CoMpound B;ilostazol USP Related Compound B;Cilostazol Metabolite (OPC-13015);Cilostazol USP Related Compound B;2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-
CBNumber:
CB1220546
Molecular Formula:
C20H25N5O2
Molecular Weight:
367.44
MOL File:
73963-62-9.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:00

6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE Properties

Melting point 179-180°C
storage temp. -20°C Freezer
solubility Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated)
form Solid
color White to Beige
BRN 4273617

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H361d
Precautionary statements  P201-P202-P280-P308+P313-P405-P501
WGK Germany  3
HS Code  2933790002
NFPA 704
0
2 0

6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE Chemical Properties,Uses,Production

Chemical Properties

Off-White to Beige Solid

6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE Suppliers

Global( 67)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
AnalyticsStanza Inc +91-7032031309 +91-7032031309 Hyderabad, India 227 58 Inquiry
Anax Laboratories +91 (40) 6464-2010 New Delhi, India 177 0 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
sgtlifesciences pvt ltd +8617013299288 China 12382 58 Inquiry
Hefei TNJ Chemical Industry Co.,Ltd. 0551-65418684 +8618949823763 China 25363 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
Cayman Chemical Company (800) 364-9897 United States 6618 81 Inquiry
OPC-13015 3,4-Dehydro Cilostazol OPC-13015: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)propoxy]-2(1H)-Quinolinone Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) OPC-13015: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-2(1H)-Quinolinone 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]- Cilostazol Related CoMpound B 1H-tetrazol-5-yl)butoxy]- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl- Cilostazol USP Related Compound B Cilostazol Metabolite (OPC-13015) Cilostazol USP RC B 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1H-quinolin-2-one 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]quinolin-2(1H)-on... Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) (1134175) ilostazol USP Related Compound B 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)quinolin-2(1H)-one cilostazol impurity B / RC-B 73963-62-9 C20H25N5O2 Metabolites & Impurities Various Metabolites and Impurities